Scribe Therapeutics Inc. SCTX
Set alert
15.73 USD +0.31 +2.01%
As of Nov 2, 12:00 PM ET
14.31 Day range 15.87
13.50 52-week range 39.60
- YTD
- -17.08%
- 1 year
- -17.08%
- Open
- 15.58
- Prev close
- 15.42
- Mkt cap
- 297.80M
- Vol
- 155.59K
- Avg vol
- 373.91K
- EPS
- -3.84
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.31
- High
- 15.87
Financials — quick view
SCTX Revenue — quarterly 1.92M
SCTX Net income — quarterly -6.48M
SCTX EPS — quarterly -2.62
News
- Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
- Scribe Therapeutics: Underrated In-Vivo Gene Therapy Developer With Near-Term Catalyst
- Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday
- Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Rated “Moderate Buy” by Wall Street Analysts
- Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- HC Wainwright & Co. Reiterates Buy on Scribe Therapeutics, Maintains $60 Price Target
- Scribe Therapeutics Q3 EPS $(2.62) Misses $(1.05) Estimate, Sales $1.918M Miss $3.113M Estimate
Your note
Sign in to keep a note on SCTX — it syncs with the Stock Master app.